Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01472042 · ClinicalTrials.gov registry record
A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
A clinical trial, sponsored by Banyan Biomarkers.
- Completed
- Registry status
- 265
- Enrollment target
NCT01472042: Completed study, sponsored by Banyan Biomarkers.
NCT01472042 is a clinical trial that has completed, run by Banyan Biomarkers. The registered enrollment target is 265 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01472042 has completed, sponsored by Banyan Biomarkers.
- COMPLETED
- Registry status
- 265 participants
- Enrollment target
Study Summary
The purpose of this study is to study the biomarkers in subjects before and after sports-induced traumatic brain injury. The assay will be studied in a sample population of subjects over the age of 18 participating in college sports.
Interventions
- OTHER Banyan Biomarkers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-07 |
What the finished NCT01472042 record still lists
NCT01472042 is an observational study that tracks outcomes without assigning an intervention. The registered 265 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Banyan Biomarkers is the first listed.
NCT01472042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01472042 about?
NCT01472042 is a clinical study titled "A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes". The purpose of this study is to study the biomarkers in subjects before and after sports-induced traumatic brain injury. The assay will be studied in a sample population of subjects over the age of 18 participating in college sports.
What is the current status of trial NCT01472042?
This trial is currently completed. The enrollment target is 265 participants. The study started on 2011-11. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01472042?
The interventions under investigation include: Banyan Biomarkers (OTHER).
Who is sponsoring clinical trial NCT01472042?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443126 · 265 participants · Phase 1
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
- NCT05470491 · 265 participants · Phase 1
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- NCT07301905 · 265 participants · NA
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
- NCT07470853 · 265 participants · Phase 1
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia